Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

作者: A. Traboulsee , J.H. Simon , L. Stone , E. Fisher , D.E. Jones

DOI: 10.3174/AJNR.A4539

关键词:

摘要: An international group of neurologists and radiologists developed revised guidelines for standardized brain spinal cord MR imaging the diagnosis follow-up MS. A with gadolinium is recommended if nondiagnostic or presenting symptoms are at level cord. to demonstrate dissemination in time ongoing clinically silent disease activity while on treatment, evaluate unexpected clinical worsening, re-assess original diagnosis, as a new baseline before starting modifying therapy. routine should be considered every 6 months 2 years all patients relapsing The protocol includes 3D T1-weighted, T2-FLAIR, T2-weighted, post-single-dose gadolinium-enhanced T1-weighted sequences, DWI sequence. progressive multifocal leukoencephalopathy surveillance FLAIR sequences only. sagittal proton attenuation, STIR phase-sensitive inversion recovery, axial T2- T2*-weighted through suspicious lesions, and, some cases, postcontrast imaging. question being addressed provided requisition radiology report descriptive, results referenced previous studies. studies permanently retained available. current revision incorporates information techniques that have become more

参考文章(48)
K R Maravilla, S Rand, U Schmiedl, Lesion enhancement in radio-frequency spoiled gradient-echo imaging: theory, experimental evaluation, and clinical implications. American Journal of Neuroradiology. ,vol. 15, pp. 27- 35 ,(1994)
MP Sormani, J Rio, M Tintorè, A Signori, D Li, P Cornelisse, B Stubinski, ML Stromillo, X Montalban, N De Stefano, Scoring treatment response in patients with relapsing multiple sclerosis. Multiple Sclerosis Journal. ,vol. 19, pp. 605- 612 ,(2013) , 10.1177/1352458512460605
Peter A. Brex, Olga Ciccarelli, Jonathon I. O'Riordan, Michael Sailer, Alan J. Thompson, David H. Miller, A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis The New England Journal of Medicine. ,vol. 346, pp. 158- 164 ,(2002) , 10.1056/NEJMOA011341
D. T. Okuda, E. M. Mowry, B. A. C. Cree, E. C. Crabtree, D. S. Goodin, E. Waubant, D. Pelletier, Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology. ,vol. 76, pp. 686- 692 ,(2011) , 10.1212/WNL.0B013E31820D8B1D
Tarek A. Yousry, Daniel Pelletier, Diego Cadavid, Achim Gass, Nancy D. Richert, Ernst-Wilhelm Radue, Massimo Filippi, Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy Annals of Neurology. ,vol. 72, pp. 779- 787 ,(2012) , 10.1002/ANA.23676
Aziz H. Poonawalla, Ping Hou, Flavia A. Nelson, Jerry S. Wolinsky, Ponnada A. Narayana, Cervical Spinal Cord Lesions in Multiple Sclerosis: T1-weighted Inversion-Recovery MR Imaging with Phase-Sensitive Reconstruction Radiology. ,vol. 246, pp. 258- 264 ,(2008) , 10.1148/RADIOL.2463061900
Catherine M. Dalton, Peter A. Brex, Katherine A. Miszkiel, Simon J. Hickman, David G. MacManus, Gordon T. Plant, Alan J. Thompson, David H. Miller, Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Annals of Neurology. ,vol. 52, pp. 47- 53 ,(2002) , 10.1002/ANA.10240
Mike P. Wattjes, Frederik Barkhof, High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology. ,vol. 51, pp. 279- 292 ,(2009) , 10.1007/S00234-009-0512-0
L. Prosperini, V. Gallo, N. Petsas, G. Borriello, C. Pozzilli, One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis. European Journal of Neurology. ,vol. 16, pp. 1202- 1209 ,(2009) , 10.1111/J.1468-1331.2009.02708.X
J. H. Simon, R. A. Bermel, R. A. Rudick, Simple MRI Metrics Contribute to Optimal Care of the Patient with Multiple Sclerosis American Journal of Neuroradiology. ,vol. 35, pp. 831- 832 ,(2014) , 10.3174/AJNR.A3937